Syracuse University’s Vice President of Research has established the Institutional Biosafety Committee (IBC). The IBC is in place to minimize the risks related to the possession and use of biohazardous materials in research, including, human and regulated plant and animal pathogens, infectious material, Select Agents, and human samples. The IBC has the authority to review and approve research practices and procedures involving biohazardous material, and to take appropriate actions to ensure activities are conducted in compliance with applicable regulations and the University’s Biosafety Program.
IBC Public Request Policy [PDF]